New MyoCycle Models on Market After MYOLYN Wins FDA Clearance
The second version of the MyoCycle, a functional electrical stimulation (FES) bike designed for people with motor disabilities, including…
​​Vanda is a biochemist with a PhD in biomedicine from the University of Porto, Portugal. She conducted her postdoctoral research first at the Bristol Medical School, U.K., studying the insulin-PI3K/Akt signaling pathway in diabetic nephropathy, then at the Institute of Molecular Pathology and Immunology of the University of Porto, where her focus was on glycosylation in lupus nephritis and inflammatory bowel disease. She next made the switch to science publishing, handling papers in biochemistry, molecular biology, and immunology.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
The second version of the MyoCycle, a functional electrical stimulation (FES) bike designed for people with motor disabilities, including…
Alpha Motor Corporation, an electric vehicle company based in Irvine, California, will donate 100% of net proceeds of sales…
Boston Scientific has received approval from the U.S. Food and Drug Administration (FDA) for its Vercise Neural Navigator with…
Nitrase Therapeutics has received a second grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to…
Kurarinone, a compound derived from a plant in the pea family and part of traditional Chinese medicine, was found to…
According to an online survey, the COVID-19 pandemic negatively affected the caregivers of patients with Parkinson’s disease, with…
An almost €2 million (about $2.3 million) EU-funded project is advancing the understanding of how damaged or abnormal cell parts…
Eight grants worth a total of $575,000 were awarded by the McCamish Parkinson’s Disease Innovation Program to research teams at…
In mice with a harmful mutation in the leucine-rich repeat protein kinase 2 (LRRK2) gene, one of the most common…
BiomeBank is launching a trial in Australia to test whether its fecal microbiota transplantation therapy, which works to replenish gut…
Get regular updates to your inbox.